Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Hynes

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 24, 2013
Loss of Memo, a novel FGFR regulator, results in reduced lifespanBarbara Haenzi, Olivier Bonny, Régis Masson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockadePatrizia Sini, Lorenza Wyder, Christian Schnell, et al.
Breast Cancer Research : BCR|October 16, 2012
Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretionNicola Aceto, Stephan Duss, Gwen MacDonald, et al.
Growth Factors (Chur, Switzerland)|March 20, 2014
EGF receptor family: twisting targets for improved cancer therapiesAntony W Burgess, Yoav I Henis, Nancy E Hynes, et al.
Breast Cancer Research : BCR|January 25, 2013
Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer modelsAmine Issa, Jason W Gill, Marinus R Heideman, et al.
Developmental Biology|January 10, 2016
MEMO1 drives cranial endochondral ossification and palatogenesisEric Van Otterloo, Weiguo Feng, Kenneth L Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasationDmitriy Kedrin, Jeffrey Wyckoff, Pamela J Boimel, et al.
Plos One|July 25, 2020
Elevated serum magnesium lowers calcification propensity in Memo1-deficient miceMatthias B Moor, Suresh K Ramakrishnan, Finola Legrand, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 5, 2003
Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigenMylène Dorvillius, Vèronique Garambois, Didier Pourquier, et al.
Nature Communications|July 14, 2016
Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer modelsAlessia Bottos, Dagmar Gotthardt, Jason W Gill, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 24, 2013
Loss of Memo, a novel FGFR regulator, results in reduced lifespanBarbara Haenzi, Olivier Bonny, Régis Masson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockadePatrizia Sini, Lorenza Wyder, Christian Schnell, et al.
Breast Cancer Research : BCR|October 16, 2012
Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretionNicola Aceto, Stephan Duss, Gwen MacDonald, et al.
Growth Factors (Chur, Switzerland)|March 20, 2014
EGF receptor family: twisting targets for improved cancer therapiesAntony W Burgess, Yoav I Henis, Nancy E Hynes, et al.
Breast Cancer Research : BCR|January 25, 2013
Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer modelsAmine Issa, Jason W Gill, Marinus R Heideman, et al.
Developmental Biology|January 10, 2016
MEMO1 drives cranial endochondral ossification and palatogenesisEric Van Otterloo, Weiguo Feng, Kenneth L Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasationDmitriy Kedrin, Jeffrey Wyckoff, Pamela J Boimel, et al.
Plos One|July 25, 2020
Elevated serum magnesium lowers calcification propensity in Memo1-deficient miceMatthias B Moor, Suresh K Ramakrishnan, Finola Legrand, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 5, 2003
Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigenMylène Dorvillius, Vèronique Garambois, Didier Pourquier, et al.
Nature Communications|July 14, 2016
Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer modelsAlessia Bottos, Dagmar Gotthardt, Jason W Gill, et al.
Pageof 9